![]() | Up a level |
Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Finn, Richard S
ORCID: 0000-0003-2494-2126, Qin, Shukui, Han, Kwang-Hyub, Ikeda, Kenji, Cheng, Ann-Lii
ORCID: 0000-0002-9152-6512, Vogel, Arndt
ORCID: 0000-0003-0560-5538, Tovoli, Francesco
ORCID: 0000-0002-8350-1155, Ueshima, Kazuomi
ORCID: 0000-0002-7577-5789, Aikata, Hiroshi
ORCID: 0000-0002-3409-2156 et al (show 10 more authors)
(2023)
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
Journal of hepatology, 78 (1).
pp. 133-141.
Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H ORCID: 0000-0002-7147-5703 et al (show 16 more authors)
(2022)
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
CLINICAL CANCER RESEARCH, 28 (12).
pp. 2547-2554.